SEPTInvestingStart Free

PCRX SC TO-T: Tender offer

Filed with the SEC on · accession 0001140361-26-043435

PCRX filed a SC TO-T (sc to-t) with the SEC on Nov 12, 2026. Viatris Inc., through its subsidiary Peach Purchaser Sub Inc., amended its tender offer statement for the acquisition of Pacira BioSciences at $36.50 per share in cash. The stock moved +0.0% by the first close after the filing.

Summary of the filing

Viatris Inc., through its subsidiary Peach Purchaser Sub Inc., amended its tender offer statement for the acquisition of Pacira BioSciences at $36.50 per share in cash. The amendment discloses two stockholder lawsuits and fifteen demand letters alleging that Pacira's Schedule 14D-9 omitted or misrepresented material information about the merger.

For details, click here →

Key details

Offer price per share of Pacira common stock$37
Parent of offerorViatris Inc.
Offeror, wholly owned subsidiary of viatrisPeach Purchaser Sub Inc.
Subject company of the tender offerPacira BioSciences, Inc.
Chief legal officer, viatris inc.Matthew J. Maletta
President, peach purchaser sub inc.Michael Rainerman

How PCRX stock reacted

Close before

$36.46

Nov 11, 2026

First close after

+0.00%

$36.46

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for PCRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PCRX?

Click here

Frequently asked questions

What did PCRX file with the SEC on Nov 12, 2026?

PCRX filed a SC TO-T (Tender offer). Viatris Inc., through its subsidiary Peach Purchaser Sub Inc., amended its tender offer statement for the acquisition of Pacira BioSciences at $36.50 per share in cash. The amendment discloses two stockholder lawsuits and fifteen demand letters alleging that Pacira's Schedule 14D-9 omitted or misrepresented material information about the merger.

What does a tender offer mean for PCRX stock?

A contract important enough that investors need to know about it — a big customer contract, a loan, a merger agreement or a partnership.

How do I read a SC TO-T?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SC TO-T (sc to-t): A report the company filed with the SEC (the US market regulator).

How did PCRX stock react to this filing?

PCRX closed at $36.46 before the filing and $36.46 on Nov 12, 2026 (+0.00%).

Other PCRX SEC filings

Get alerts when PCRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
PCRX overviewPCRX analysisPCRX newsLatest SEC filings